Quadrise PLC - MAC2 Services Agreement
Quadrise Plc
("Quadrise", "QED" or the "Company")
Signature of MAC2 Services Supply Agreement
Quadrise Plc (AIM: QED), the supplier of innovative energy solutions for a cleaner planet, is pleased to announce the signature of a Services Supply Agreement ("Agreement") with MAC2 Solutions NV ("MAC2") with regard to the production of MSAR® and bioMSAR™ fuels for the Company's forthcoming marine vessel trials on board the MSC Leandra V, expected to commence in Q2 2025 (the "Trials").
The Trials will comprise an initial Proof of Concept period using MSAR® and then bioMSAR™ for performance baseline tests, followed by 4,000 hours of operation (approximately 6-8 months) on bioMSAR™ in order to obtain a letter of no objection from engine manufacturer Wärtsilä upon success.
The Agreement sets out the responsibilities of Quadrise and MAC2 in respect of the Trials, which will be carried out following the installation and commissioning of Quadrise equipment at the MAC2 facility in
The remaining bilateral agreements to facilitate the Trials, including a toll manufacturing agreement between Cargill BV ("Cargill") and Quadrise in respect of fuel manufacture, continue to be advanced and further announcements will be made in due course.
Alongside the Trials, the parties plan to initiate commercial MSAR® and bioMSAR™ bunker supply operations to the marine sector through the MAC2 facilities in the
Commenting on the update,
"We are pleased to have signed this services agreement with MAC2 to progress our plans for supplying MSAR® and bioMSAR™ to the marine sector from Antwerp-Bruges. We look forward to working with them as we prepare for the trials on the MSC Leandra V in Q2 2025 and to a successful longer-term partnership as we progress to commercial supply."
For additional information, please contact:
|
Quadrise Plc |
|
+44 (0)20 7031 7321 |
|
|
|
|
|
|
|
|
|
Nominated Adviser |
|
|
|
Cavendish Capital Markets Limited |
|
+44 (0)20 7220 0500 |
|
|
|
|
|
|
|
|
|
Joint Brokers Shore Capital Stockbrokers Limited |
|
+44 (0)20 7408 4090 |
|
|
|
|
|
|
|
|
|
|
|
|
|
VSA Capital Limited |
|
+44 (0)20 3005 5000 |
|
|
|
|
|
Public & Investor Relations |
|
|
|
BLUE Communications Limited
|
|
+44 (0) 7595 227750 +44 (0)7527 558846 |
About Quadrise
Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.
Learn more at: www.quadrise.com
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE